Schoch Charles
- SEC CIK
- 0002007349
No open-market purchases or sales filed in the past year.
Current role at each company
- CADL Candel Therapeutics, Inc.Chief Financial Officeras of Jan 28, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Schoch Charles as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2025 (view filing) | Mar 17 | 2 days | Schoch CharlesSee Remarks | SSale | −5.00K | $8.83 | −$44.1K | −11.6%38.0K after | 10b5-1 |
| Jan 17, 2025 (view filing) | Jan 15 | 2 days | Schoch CharlesSee Remarks | SSale | −9.51K | $7.23 | −$68.8K | −18.1%43.0K after | |
| Jan 10, 2025 (view filing) | Jan 8 | 2 days | Schoch CharlesSee Remarks | SSale | −9.97K | $8.22 | −$82.0K | −15.9%52.5K after | |
| Jul 19, 2024 (view filing) | Jul 17 | 2 days | Schoch CharlesSee Remarks | SSale | −9.88K | $6.47 | −$63.9K | −13.7%62.5K after | |
| Jul 15, 2024 (view filing) | Jul 11 | 4 days | Schoch CharlesSee Remarks | SSale | −8.90K | $5.97 | −$53.1K | −10.9%72.4K after |